FHIR Release 3 (STU) R4 Ballot #2 (Mixed Normative/Trial use)

This page is part of the FHIR Specification (v3.0.2: STU 3). (v3.5.0: R4 Ballot #2). The current version which supercedes this version is 5.0.0 . For a full list of available versions, see the Directory of published versions . Page versions: R5 R4B R4 R3

Medicationexample0318

Pharmacy Work Group Maturity Level : N/A Ballot Status : Informative Compartments : Not linked to any defined compartments

This is the narrative for the resource. See also the XML or , JSON or Turtle format. This example conforms to the profile Medication .

Generated Narrative with Details

id : med0318

isBrand : false form : Injection emulsion (Details : {SNOMED CT code '385221006' = 'Injection emulsion', given as 'Injection emulsion'})

ingredient

item : Clinimix 4.25/10 sulfite-free (4.25% Amino Acid in 10% Dextrose) Injection, 1000ml (Details : {http://hl7.org/fhir/sid/ndc code '0338-1134-03' = '0338-1134-03', given as 'Clinimix 4.25/10 sulfite-free (4.25% Amino Acid in 10% Dextrose) Injection, 1000ml'})

ingredient

item : TPN Electrolytes SODIUM CHLORIDE, CALCIUM CHLORIDE, POTASSIUM CHLORIDE, MAGNESIUM CHLORIDE, and SODIUM ACETATE ANHYDROUS | INJECTION, SOLUTION, CONCENTRATE | 321 mg/20mL, 331 mg/20mL, 1491 mg/20mL, 508 mg/20mL, 2420 mg/20mL (Details : {http://hl7.org/fhir/sid/ndc code '0409-5779-01' = '0409-5779-01', given as 'TPN Electrolytes SODIUM CHLORIDE, CALCIUM CHLORIDE, POTASSIUM CHLORIDE, MAGNESIUM CHLORIDE, and SODIUM ACETATE ANHYDROUS | INJECTION, SOLUTION, CONCENTRATE | 321 mg/20mL, 331 mg/20mL, 1491 mg/20mL, 508 mg/20mL, 2420 mg/20mL'})

ingredient

item : Intralipid 20% IV Fat Emulsion (Details : {http://hl7.org/fhir/sid/ndc code '0338-0519-02' = '0338-0519-02', given as 'Intralipid 20% IV Fat Emulsion'})

package container : Intravenous Fluid container, single-use (Details : {SNOMED CT code '470037004' = 'Intravenous fluid container, single-use', given as 'Intravenous Fluid container, single-use'})

Batches

- LotNumber ExpirationDate
* 123455 09/07/2016

 

 

Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.